Concepedia
Statistics
Publications
19
Citations
2.6K
H-Index
Active since
1984
Affiliations
National Cancer Institute(Current)
National Institutes of Health
Duke Medical Center
National Cancer Institute
The US Oncology Network
James W. Hathorn is an author at National Cancer Institute specializing in oncology, antimicrobial pharmacotherapy, and pharmacy.
Publications per year
1984–2017
A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia
Philip A. Pizzo, James W. Hathorn, John Hiemenz et al. · New England Journal of Medicine · 1986 · 593 citations
Pharmacy, Oncology, Pharmacotherapy +14
Gram-Positive Infections and the Use of Vancomycin in 550 Episodes of Fever and Neutropenia
Marc Rubin, James W. Hathorn, D. Marshall et al. · Annals of Internal Medicine · 1988 · 285 citations
Pharmacy, Oncology, Pharmacology +17
Preoperative Radiation and Chemotherapy in the Treatment of Adenocarcinoma of the Rectum
Ravi S. Chari, Douglas S. Tyler, Mitchell S. Anscher et al. · Annals of Surgery · 1995 · 264 citations
Medicine, Oncology, Surgery +17
Detection of Circulating Candida Enolase by Immunoassay in Patients with Cancer and Invasive Candidiasis
Thomas J. Walsh, James W. Hathorn, Jack D. Sobel et al. · New England Journal of Medicine · 1991 · 246 citations
Veterinary Medicine, Infectious Diseases, Microbiology +12
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Alison G. Freifeld, Thomas J. Walsh, David Marshall et al. · Journal of Clinical Oncology · 1995 · 213 citations
Pharmacy, Pharmacology, Pharmacotherapy +16
1–5 of 19